[Medical support of nicotine withdrawal. Report on a double blind trail in over 5000 smokers (author's transl)].
D002951:Citrates / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003967:Diarrhea / Q000139:chemically induced; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D006261:Headache / Q000139:chemically induced; D006801:Humans; D010919:Placebos; D011189:Potassium Chloride / Q000009:adverse effects / Q000627:therapeutic use; D012836:Silver Proteins / Q000009:adverse effects / Q000627:therapeutic use; D012907:Smoking / Q000188:drug therapy*; D013651:Taste Disorders / Q000139:chemically induced
D002951:Citrates; D010919:Placebos; D012836:Silver Proteins; D011189:Potassium Chloride
Medikamentöse Unterstützung der Raucherentwöhnung. Bericht über Versuche an über 5000 Rauchern im Doppelblindversuch.